290
Views
19
CrossRef citations to date
0
Altmetric
Original Articles

In vivo comparison of wound healing and scar treatment effect between curcumin–oligochitosan nanoparticle complex and oligochitosan-coated curcumin-loaded-liposome

, , , ORCID Icon, , , , , , & show all
Pages 156-168 | Received 18 Feb 2019, Accepted 17 Apr 2019, Published online: 23 May 2019
 

Abstract

This study aimed to compare the in vivo effectiveness between curcumin–oligochitosan nanoplexes (CUR–OCH nanoplexes) and oligochitosan-coated curcumin-encapsulated liposomes (OCH-Lip-CUR) with respect to wound healing and scar treatment. Firstly, CUR-OCH nanoplexes was prepared by drug-polysaccharide complexation method and OCH-Lip-CUR was prepared by a combining method of lipid-film hydration and sonication. Their in vitro cytotoxicity and in vivo wound healing and scar treatment effectiveness were evaluated using 3T3 cells and mice Mus musculus var. Albino, respectively. The resutls indicated that both of them were in nanosize with a moderate PDI (less than 0.3), and exhibited negligible cytotoxicity at low CUR concentration (0.01 mg/mL). Moreover, their application onto wounds resulted in faster healing and higher scar treatment effectiveness than control samples. Interestingly, OCH-Lip-CUR exhibited higher in vivo effectiveness than CUR-OCH nanoplexes. However, based on their own advantages, both of them were good candidates for a commercial formulation for wound healing and scar treatment.

Acknowledgements

The authors would like to acknowledge the School of Life Sciences and Biotechnology, Korea University, South of Korea for the contribution to this work.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This study received research funding from Vietnam Atomic Energy Institute and Nuclear Research Institute (Grant number: 07/17/VNCHN).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.